TrialX
Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 3,739 clinical trials

S Shao Feng, Doctor

Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 in Healthy Subjects

This is a single-dose/multiple-doses incremental, randomized, double-blind, parallel, placebo-controlled study on safety, tolerance and pharmacokinetics healthy subjects.

18-65 years All Phase 1
C Chu Kay Michael MAK, FRCSEd(Orth)

Arthroscopic Debridement vs Arthroscopic Hemi-Trapeziectomy on Patients With Thumb Carpometacarpal Joint Osteoarthritis

Patients with thumb carpometacarpal joint osteoarthritis usually suffer from pain, joint enlargement, inflammation, deformity and loss of function. Conservative treatments usually are the first-line interventions, unfortunately some of the patients do not response to such treatments and surgical treatment will then be considered. Compare to other traditional surgical techniques, arthroscopic …

18 years and older All Phase N/A
F Fernanda Visioli, PhD

Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis

Actinic cheilitis is a potentially malignant lesion on the lower lip, which can progress to more serious illnesses such as cancer if not treated. Usually treatment of this condition is only based on clinical appearance, but there is no established cure treatment. Topical imiquimod is a medicine indicated for the …

18-85 years All Phase 2/3
E EA Pharma Co., Ltd. Public Relations Group, Corporate Planning Dept.

A Study to Evaluate the Safety Tolerability Pharmacokinetics Pharmacodynamics Bioavailability and Food-effects of EA1080 in Healthy Caucasian and Japanese Male Participants

The primary purpose of the study is to evaluate the safety and tolerability of EA1080 following single and multiple oral doses in healthy Caucasian and Japanese male participants.

18-45 years Male Phase 1
A Astellas Pharma Global Development, Inc.

A Study to Evaluate Enfortumab Vedotin in Subjects With Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

The primary purpose of this study is to determine the antitumor activity of enfortumab vedotin as measured by confirmed objective response rate (ORR). This study will also assess other measures of antitumor activity; overall survival (OS); as well as the safety and tolerability of enfortumab vedotin.

18 years and older All Phase 2
T Tim Overkamp, Dr.

Patients With ES-SCLC and ECOG PS=2 Receiving Atezolizumab-Carboplatin-Etoposide

Small cell lung cancer (SCLC) is a rapidly proliferating, neuroendocrine tumor that accounts for about 15% of all lung cancers. Most patients have metastases at primary diagnosis involving sites like bone, adrenal glands, liver and brain. Compared with non-small-cell lung cancer (NSCLC) SCLC has a unique natural history with a …

18 years and older All Phase 2
S Sarah A Mossman, MACPR

Trial With the Treatment of Sertraline in Youth With Generalized Separation and/or Social Anxiety Disorders.

A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.

8-17 years All Phase 4
S Stephen Bagley, MD, MSCE

Anti-GITR/Anti-PD1/Stereotactic Radiosurgery in Recurrent Glioblastoma

This is a phase II study of the combination of the GITR agonist monoclonal antibody INCAGN01876, the anti-PD1 monoclonal antibody INCMGA00012, and stereotactic radiosurgery (SRS) for recurrent Glioblastoma (GBM). The investigators hypothesize that the proposed regimen will be safe and stimulate a robust anti-tumor immune response and result in improved …

18 years and older All Phase 2
Y Yousra H Abdel Fattah, PhD

Outcome of Facial Palsy Following Rehabilitation

Retrospective case series,the aim of this study is to assess the outcome and rate of complications in patients with facial palsy following rehabilitation, a retrospective study.

100 years and younger All Phase N/A
P Peiwen Lian, PhD

Study of NK Combined With Chemotherapy for Advanced Solid Tumor

Combinations Natural Killer Cell (NK) With chemotherapy treatment may enhance the immune response and stop cancer cells from growing.

10-90 years All Phase N/A

Simplify language using AI